Dewpoint Therapeutics
PrivateLast Round
Series B
Jul 13, 2026
Total Funding Raised
$346.1M
Company Overview
Dewpoint Therapeutics is a biotechnology company that develops small molecule medicines targeting biomolecular condensates to treat intractable conditions including cancer, neurodegeneration, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dewpoint Therapeutics Comparables
Compare Dewpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transition Bio | 88% | |
| Nereid Therapeutics | 84% | |
| ETERN Therapeutics | 84% | |
Dewpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 13, 2026 | ||||
| Series D | Sep 10, 2025 | ||||
| Series C | Feb 3, 2022 | ||||
| Series B | Sep 29, 2020 | ||||
| Series A | Jan 30, 2019 |
Key People
Founding team and executive leadership
Dewpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series B, Series A |
| SoftBank Investment Advisers | Series C |
| Maverick Ventures | Series C, Series A, Series B |
| Bencao Capital | Series C |
| Innovation Endeavors | Series B |
| ARCH Venture Partners | Series C, Series B |
| SoftBank Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Presented preclinical data on Oral MYC condensate modulator at AACR 2026.
- Apr 21, 2026
Presented data at the AACR 2026 conference.
Dewpoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dewpoint Therapeutics's valuation, stock price, and market status.